Skip to main content
eScholarship
Open Access Publications from the University of California

UC Santa Cruz

UC Santa Cruz Previously Published Works bannerUC Santa Cruz

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

  • Author(s): Roberts, Lewis R
  • Farshidfar, Farshad
  • Zheng, Siyuan
  • Gingras, Marie-Claude
  • Newton, Yulia
  • Shih, Juliann
  • Robertson, A Gordon
  • Hinoue, Toshinori
  • Hoadley, Katherine A
  • Gibbs, Richard
  • Roszik, Jason
  • Covington, Kyle
  • Wu, Chia-Chin
  • Shinbrot, Eve
  • Stransky, Nicolas
  • Hegde, Apurva M
  • Yang, Ju Dong
  • Reznik, Ed
  • Sadeghi, Sara
  • Pedamallu, Chandra Sekhar
  • Ojesina, Akinyemi I
  • Hess, Julian
  • Auman, J Todd
  • Rhie, Suhn K
  • Bowlby, Reanne
  • Borad, Mitesh J
  • Stuart, Josh
  • Sander, Chris
  • Akbani, Rehan
  • Cherniack, Andrew D
  • Laird, Peter W
  • Deshpande, Vikram
  • Mounajjed, Taofic
  • Foo, Wai Chin
  • Torbenson, Michael
  • Kleiner, David E
  • Wheeler, David A
  • Mcree, Autumn J
  • Bathe, Oliver F
  • Andersen, Jesper B
  • Bardeesy, Nabeel
  • Kwong, Lawrence N
  • et al.
Abstract

Cholangiocarcinoma (CCA) is an aggressive malignancy of the bile ducts, with poor prognosis and limited treatment options. Here, we describe the integrated analysis of somatic mutations, RNA expression, copy number, and DNA methylation by The Cancer Genome Atlas of a set of predominantly intrahepatic CCA cases and propose a molecular classification scheme. We identified an IDH mutant-enriched subtype with distinct molecular features including low expression of chromatin modifiers, elevated expression of mitochondrial genes, and increased mitochondrial DNA copy number. Leveraging the multi-platform data, we observed that ARID1A exhibited DNA hypermethylation and decreased expression in the IDH mutant subtype. More broadly, we found that IDH mutations are associated with an expanded histological spectrum of liver tumors with molecular features that stratify with CCA. Our studies reveal insights into the molecular pathogenesis and heterogeneity of cholangiocarcinoma and provide classification information of potential therapeutic significance.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View